Evidence map›Paper›PMID 38169170›Full record

ArticleBiochimica et biophysica acta. Proteins and proteomics2024

Biophysical characterization of human-cell-expressed, full-length κI O18/O8, AL-09, λ6a, and Wil immunoglobulin light chains.

Pinaki Misra, Alexander Tischer, Lindsey Lampe, Valeria Pierluissi-Ruiz, Christopher J Dick, Benoit Bragantini, Nikita Kormshchikov, Matthew Auton, Marina Ramirez-Alvarado

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta. Proteins and proteomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Pinaki MisraDepartment of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. Electronic address: misra.pinaki@mayo.edu.
Alexander TischerDepartment of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN, USA. Electronic address: tischer.alexander@mayo.edu.
Lindsey LampeDepartment of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Valeria Pierluissi-RuizDepartment of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Christopher J DickDepartment of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Benoit BragantiniDepartment of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Nikita KormshchikovDepartment of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Matthew AutonDepartment of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN, USA.
Marina Ramirez-AlvaradoDepartment of Biochemistry and Molecular Biology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA; Department of Immunology, Mayo Clinic, 200 First St SW, Rochester, MN, USA. Electronic address: ramirezalvarado.marina@mayo.edu.
Mayo Clinic · US

Funding

Post-baccalaureate Training in Biomedical ResearchR25GM075148 · NIGMS · MAYO CLINIC ROCHESTER · PI LUJAN, LUIS, MAHER, LOUIS JAMES · 2006 to 2024
$6.1M
Cellular, kinetic, and structural mechanisms of toxicity in light chain amyloidosisR01GM128253 · NIGMS · MAYO CLINIC ROCHESTER · PI RAMIREZ-ALVARADO, MARINA · 2018 to 2021
$1.6M
NIGMS NIH HHS R01 GM128253NIGMS NIH HHS R25 GM075148
6 · The paper itself

Abstract

Immunoglobulin light chain (AL) amyloidosis involves the deposition of insoluble monoclonal AL protein fibrils in the extracellular space of different organs leading to dysfunction and death. Development of methods to efficiently express and purify AL proteins with acceptable standards of homogeneity and structural integrity has become critical to understand the in vitro and in vivo aspects of AL protein aggregation, and thus the disease progression. In this study, we report the biophysical characterization of His-tagged and untagged versions of AL full-length (FL) κI and λ6 subgroup proteins and their mutants expressed from the Expi293F human cell line. We used an array of biophysical and biochemical methods to analyze the structure and stability of the monomers, oligomerization states, and thermodynamic characteristics of the purified FL proteins and how they compare with the bacterially expressed FL proteins. Our results demonstrate that the tagged and untagged versions of FL proteins have comparable stability to proteins expressed in bacterial cells but exhibit multiple unfolding transitions and reversibility. Non-reducing SDS-PAGE and analytical ultracentrifugation analysis showed presence of monomers and dimers, with an insignificant amount of higher-order oligomers, in the purified fraction of all proteins. Overall, the FL proteins were expressed with sufficient yields for biophysical studies and can replace bacterial expression systems.

Indexed as

Antibodies, MonoclonalImmunoglobulin Light ChainsBiophysicsCell LineDisease ProgressionHumansAntibodies, MonoclonalImmunoglobulin Light ChainsAL amyloidosisAL full-length proteinsCircular dichroismFluorescenceMammalian cell protein expression

Identifiers

PMID38169170
PMCPMC10939777
OpenAlexW4390460471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.